diabetestalk.net

Insulin Production Genetic Engineering

Share on facebook

Genetic Engineering

Genetic engineering is the process by which a functional gene is introduced into a new tissue or organ in order for it to express a new characteristic or feature. Genetic engineering, in the form of 'gene therapy', reached the public media through attempts in the early 1990s to cure severe combined immunodeficiency disorder (SCID; otherwise known as 'bubble boy disease'). Investigators in type 1 diabetes, as in many other fields of medicine, rushed into this promising area; leading objectives were modification of islet cells to render them resistant to immune destruction prior to transplantation, altering various cell types to convert them into insulin-producing cells for later transplantation into the same individual, or altering bone marrow cells in such a way that they would improve therapeutic outcomes (such as prevention of late complications) following transplantation. Sadly, the reality of genetic engineering did not match its promise, and scientific research in this area declined dramatically in recent years relative to a decade ago. However, progress in other medical disciplines over the same time period has recently rekindled interest in this otherwise promising notion. I Continue reading >>

Share on facebook

Popular Questions

  1. gil_bz

    In order to put human DNA inside a bacteria in order to have it create Insulin, from what type of cell would you need to take the gene for insulin? I thought it should be from any somatic cell, since the DNA is identical, but I'm told it should be only from the pancreas, why is that?

  2. January

    In short, because the easiest way to get the protein coding sequence of the gene is to create cDNA based on the mRNA, and insulin mRNA is only expressed in pancreatic cells.
    Insulin gene consists of two exons. That means, amplifying the genome will not give us a coding sequence -- two pieces of that sequence will be interrupted by a large, non-coding intron.
    On the figure above, you see the translated (i.e., coding a protein) sequences represented as opaque boxes. They are linked by a slightly curving thin line -- this is a fragment of sequence that will get excised during mRNA maturation.
    To get the coding sequence in a straightforward manner, one can create cDNA from mRNA using a reverse transcriptase. Processed mRNA does not contain the intron. And clearly, pancreas cells express the insulin gene mRNA at very high levels, enabling such a procedure, whereas it is practically not expressed by other tissues.
    EDIT: Since I see these comments upvoted, I need to debunk them here:

    There are introns and splicing in both, bacteria and archea. Both type I and type II introns are present in bacteria. See this review on bacterial type II introns.

    Bacteria also have post-translational modifications, including glycosylation. Once thought to be rare, there is an increasing body of evidence that it plays a much more important role than previously thought. See a paper from a decade ago here.

  3. -> Continue reading
read more close

Related Articles

Popular Articles

More in insulin